May 27, 2020 – The U.S Food and Drug Administration said on Wednesday it had found high levels of a possible cancer-causing impurity in some versions of the popular diabetes drug metformin.
The agency is reaching out to companies whose drugs had N-nitrosodimethylamine (NDMA) over accepted levels and will take appropriate action, a spokesman for the FDA said in an emailed statement.
Bloomberg, which first reported the FDA’s findings, said that some recalls of metformin were expected as soon as this week, citing a person familiar with the matter.
Online pharmacy Valisure said in March that its independent tests showed high levels of NDMA in metformin made by 11 companies, including Amneal Pharmaceuticals Inc and Aurobindo Pharma Ltd.
WHO DO YOU SUE? – Dec. 18, 2024 - The U.S. Food and Drug Administration…
VIDEO – MUSICAL INTERLUDE – 1965 - 786,695 views Since Aug 4, 2022 - Soprano Saxophone…
VIDEO – MERRY CHRISTMAS EVE – 1965 - 1,465,813 views since Jan 20, 2010…
AUDIO – WELLNESS FARMS COMING? – Dec. 17, 2024 - Robert F. Kennedy, Jr., President-elect…
‘TIS THE SEASON... – Dec, 18, 2024 - “There’s already an excuse to start drinking…
VIDEO ONLY – METHADONE FOR ALL MY FRIENDS – Dec. 20, 2024 - Millions of…